STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)

NCT07743138 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Adrenocortical Carcinoma
Pheochromocytoma
Paraganglioma

Interventions

DRUG: Ivonescimab

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]